A study published in the January, 2014 edition of British Medical Journal titled “Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.” by S. Grigoriadis et al. provides further insight into the relationship between SSRI use during pregnancy and persistent pulmonary hypertension of the newborn (PPHN).
Reviewing seven previously-conducted studies, the research team found that exposure to SSRI drugs in late pregnancy was associated with a risk for persistent pulmonary hypertension of the newborn increased by 250%.
Due to the fact that many women have used SSRIs unaware of the risk for persistent pulmonary hypertension of the newborn, as warning labels for these drugs have failed to adequately warn women of these risks (even in light of a great deal of scientific evidence supporting them), a number of SSRI lawsuits have been filed.
If you or a loved one used SSRIs and gave birth to a child with PPHN, please do not hesitate to contact our team of SSRI birth defect lawyers for a free consultation. You may be entitled to significant financial compensation you and your child have endured. At your convenience, contact our team at the information provided below. We have the experience, resources, and skills required to win the justice you deserve. Call today and see how we can help.
(855) 452 – 5529